Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Bluefish Pharmaceuticals AB (publ)

Closing information (x1000 NOK)

Closing information 2023/04 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 559,907 Less Arrow 375,948 More Arrow 434,145
Financial expenses 42,663 Less Arrow 15,016 Less Arrow 8,958
Earnings before taxes -93,477 More Arrow -18,504 More Arrow 37,716
EBITDA -28,553 More Arrow 17,168
Total assets 560,551 Less Arrow 554,071 Less Arrow 525,705
Current assets 426,519 More Arrow 446,540 Less Arrow 389,466
Current liabilities 210,021 More Arrow 445,679 Less Arrow 222,086
Equity capital -43,177 More Arrow 86,499 More Arrow 113,316
- share capital 22,376 Less Arrow 21,049 More Arrow 22,611
Employees (average) 128 Less Arrow 124 More Arrow 129

Financial ratios

Fiscal year 2023/04 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency -7.7% More Arrow 15.6% More Arrow 21.6%
Turnover per employee 4,374 Less Arrow 3,032 More Arrow 3,365
Profit as a percentage of turnover -16.7% More Arrow -4.9% More Arrow 8.7%
Return on assets (ROA) -9.1% More Arrow -0.6% More Arrow 8.9%
Current ratio 203.1% Less Arrow 100.2% More Arrow 175.4%
Return on equity (ROE) 216.5% Less Arrow -21.4% More Arrow 33.3%
Change turnover 160,267 Less Arrow -28,201 More Arrow 36,164
Change turnover % 40% Less Arrow -7% More Arrow 9%
Chg. No. of employees 4 Less Arrow -5 Less Arrow -20
Chg. No. of employees % 3% Less Arrow -4% Less Arrow -13%

Total value of public sale

Fiscal year 2023/04 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.